Download Sample
Add to CartSleeping Bruxism Treatment Market
By Type;
Primary Bruxism and Secondary BruxismBy Diagnosis;
Clinical Examination , X-Rays, Electromyographic Methods, and PolysomnographyBy Treatment Type;
Dental Approaches and MedicationBy Cause;
Obstructive Sleep Apnea , Gastroesophageal Reflux Disease (GERD), Malocclusion, and Sleep ParalysisBy End User;
Hospitals and Dental ClinicsBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Sleeping Bruxism Treatment Market Overview
Sleeping Bruxism Treatment Market (USD Million)
Sleeping Bruxism Treatment Market was valued at USD 796.09 million in the year 2024. The size of this market is expected to increase to USD 1,919.79 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 13.4%.
Sleeping Bruxism Treatment Market
*Market size in USD million
CAGR 13.4 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 13.4 % |
| Market Size (2024) | USD 796.09 Million |
| Market Size (2031) | USD 1,919.79 Million |
| Market Concentration | Low |
| Report Pages | 337 |
Major Players
- Ivoclar Vivadent AG
- Ipsen Biopharmaceuticals, Inc.
- Merz Pharma GmbH & Co. KGaA
- Carestream Dental 1
- Akervall Technologies Inc
- PLANMECA OY
- Randmark Dental Products, LLC
- S4S Dental Laboratory
- Patterson Dental Supply, Inc.
- Pfizer Inc.
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Sleeping Bruxism Treatment Market
Fragmented - Highly competitive market without dominant players
The Sleeping Bruxism Treatment Market is witnessing strong growth due to increasing awareness of this sleep-related condition. Nearly 15% of adults and about 20% of children are affected, underlining its widespread nature. Greater recognition of its connection to jaw pain, tooth wear, and sleep disturbances has heightened the focus on effective treatment methods.
Shift Toward Non-Invasive Solutions
A large portion of patients are showing preference for non-invasive therapies like oral splints and mouthguards. Surveys indicate that nearly 60% of individuals choose removable devices over invasive procedures for comfort and affordability. This demand is encouraging dental solution providers to innovate with customizable and patient-friendly products.
Role of Technology in Treatment Advancements
The adoption of digital tools and smart monitoring devices has modernized how bruxism is managed. More than 35% of dental practices utilize sleep tracking technologies for precise diagnosis. Such innovations improve treatment accuracy and enhance patient compliance, strengthening confidence in advanced bruxism solutions.
Healthcare Spending on Sleep Disorders
With over 25% of healthcare resources being allocated to sleep-related issues, treatments for bruxism are gaining greater importance. Rising stress-related bruxism among professionals is pushing providers to expand treatment offerings. This focus on sleep health is fostering a more integrated approach to patient care.
Sleeping Bruxism Treatment Market Recent Developments
-
In 2023, the market saw the rise of custom,made oral appliances for bruxism, which help prevent tooth damage during sleep
-
In early 2024, advancements in botulinum toxin (Botox) injections were introduced to alleviate bruxism symptoms by relaxing jaw muscles
Sleeping Bruxism Treatment Market Segment Analysis
In this report, the Sleeping Bruxism Treatment Market has been segmented by Type, Diagnosis, Treatment Type, Cause, Pateint Type, End User and Geography.
Sleeping Bruxism Treatment Market, Segmentation by Type
The Sleeping Bruxism Treatment Market has been segmented by Type into Primary Bruxism and Secondary Bruxism.
Primary Bruxism
Primary bruxism accounts for nearly 65% of the sleeping bruxism treatment market and is typically linked to non-medical causes such as stress, anxiety, and lifestyle factors. Increased awareness and demand for early intervention are driving its diagnosis and treatment.
Secondary Bruxism
Secondary bruxism holds about 35% of the market share, often associated with underlying medical conditions, neurological disorders, or the side effects of certain medications. Growing advancements in dental and neurological care are supporting its treatment adoption.
Sleeping Bruxism Treatment Market, Segmentation by Diagnosis
The Sleeping Bruxism Treatment Market has been segmented by Diagnosis into Clinical Examination , X-Rays, Electromyographic Methods and Polysomnography.
Clinical Examination
Clinical examination remains the most common diagnostic approach, accounting for around 40% of the sleeping bruxism diagnosis market. It involves physical assessment of teeth wear, jaw muscle tension, and patient history to detect signs of the condition.
X-Rays
X-rays contribute to nearly 25% of the diagnostic share, offering detailed imaging to assess dental structure damage and joint conditions. This method is widely used to rule out other underlying oral health issues.
Electromyographic Methods
Electromyographic methods hold about 20% market share, measuring muscle activity in the jaw during sleep. They provide objective data and help in monitoring treatment effectiveness over time.
Polysomnography
Polysomnography represents roughly 15% of diagnostics, being the most comprehensive method that evaluates sleep patterns, breathing, and muscle activity. It is primarily used in specialized sleep clinics for complex cases.
Sleeping Bruxism Treatment Market, Segmentation by Treatment Type
The Sleeping Bruxism Treatment Market has been segmented by Treatment Type into Dental Approaches and Medication.
Dental Approaches
Dental approaches dominate the sleeping bruxism treatment market with nearly 60% share, primarily involving customized mouthguards, splints, and bite correction techniques. These solutions help reduce teeth grinding, prevent enamel wear, and alleviate jaw strain during sleep.
Medication
Medication accounts for around 40% of the market, focusing on muscle relaxants, anti-anxiety drugs, and botulinum toxin injections. These treatments aim to reduce muscle overactivity and address underlying neurological or stress-related triggers of bruxism.
Sleeping Bruxism Treatment Market, Segmentation by Cause
The Sleeping Bruxism Treatment Market has been segmented by Cause into Obstructive Sleep Apnea , Gastroesophageal Reflux Disease (GERD), Malocclusion and Sleep Paralysis.
Obstructive Sleep Apnea
Obstructive sleep apnea is a leading cause of sleeping bruxism, contributing to nearly 35% of cases. Interrupted breathing during sleep triggers jaw clenching as a reflex action, increasing tooth wear and muscle strain.
Gastroesophageal Reflux Disease (GERD)
GERD is linked to about 25% of bruxism cases, where acid reflux irritates the throat and esophagus, causing unconscious jaw tightening. Effective management of GERD symptoms can help reduce bruxism severity.
Malocclusion
Malocclusion accounts for roughly 20% of cases, where misaligned teeth or bite irregularities lead to persistent grinding. Corrective orthodontic treatments often alleviate this mechanical trigger.
Sleep Paralysis
Sleep paralysis is responsible for around 15% of cases, with stress and disrupted REM sleep patterns prompting involuntary jaw contractions. Psychological therapy and sleep hygiene improvements can significantly reduce these episodes.
Sleeping Bruxism Treatment Market, Segmentation by End User
The Sleeping Bruxism Treatment Market has been segmented by End User into Hospitals and Dental Clinics.
Hospitals
Hospitals handle approximately 55% of sleeping bruxism treatment cases, offering advanced diagnostic facilities and multidisciplinary care. They often provide comprehensive management plans that integrate medical, dental, and behavioral therapies for effective results.
Dental Clinics
Dental clinics account for nearly 40% of treatments, focusing on specialized care such as custom mouthguards, bite correction, and tooth restoration. Their accessibility and targeted expertise make them a preferred choice for patients seeking prompt and specialized bruxism management.
Sleeping Bruxism Treatment Market, Segmentation by Geography
In this report, the Sleeping Bruxism Treatment Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
Regions and Countries Analyzed in this Report
Sleeping Bruxism Treatment Market Share (%), by Geographical Region
North America
North America leads the sleeping bruxism treatment market with around 38% share, driven by advanced dental healthcare infrastructure and high awareness levels. Increased adoption of custom dental appliances and behavioral therapies also supports growth in this region.
Europe
Europe holds approximately 27% of the market, fueled by strong healthcare systems and proactive dental care policies. The region benefits from rising preventive dentistry measures and availability of modern diagnostic tools.
Asia Pacific
Asia Pacific captures nearly 22% of the market, with growth driven by increasing dental care awareness and expanding healthcare infrastructure. Emerging economies are witnessing rising demand for affordable bruxism treatments.
Middle East & Africa
Middle East & Africa represent about 7% of the market, supported by growing investment in dental care and medical tourism. Availability of specialized dental clinics is gradually increasing across key cities.
Latin America
Latin America accounts for roughly 6% of the market, with demand rising due to improving healthcare access and increased public awareness. Growth is supported by dental outreach programs and preventive care initiatives.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Sleeping Bruxism Treatment Market. These factors include; Market Drivers, Restraints and Opportunities.
Drivers, Restraints and Opportunity Analysis
Drivers
- Increasing Prevalence Of Sleep Bruxism
-
Growing Child Population:The growing child population has significantly contributed to the increasing focus on sleeping bruxism treatment. Bruxism is relatively common among children, often manifesting during periods of mixed dentition or as a response to stress, anxiety, or developmental changes. As parents and healthcare providers become more aware of the potential long-term effects of untreated bruxism, such as dental wear, jaw misalignment, and disrupted sleep, the demand for pediatric-specific treatment solutions has risen. Custom-made night guards tailored to the smaller jaw sizes of children, as well as behavioral therapies designed for younger patients, have gained popularity. These targeted interventions aim to protect developing teeth and promote better oral and overall health.
Healthcare systems and manufacturers are increasingly addressing the needs of pediatric populations by developing innovative, child-friendly solutions. For example, lightweight, colorful, and comfortable oral appliances encourage compliance among younger users. Educational initiatives aimed at parents and schools also play a crucial role in raising awareness about bruxism and its management. As the global child population continues to grow, especially in emerging markets, the pediatric segment within the sleeping bruxism treatment market is expected to expand significantly, providing new opportunities for industry stakeholders.
Restraints
- Limited Availability Of Treatment Options
-
High Cost Of Custom Fit Night Guards:Custom-fit night guards remain one of the most effective solutions for managing sleeping bruxism; however, their high cost presents a significant barrier for many patients. These devices are typically fabricated using advanced dental impression techniques and durable materials, leading to elevated production costs. For individuals without comprehensive dental insurance, the expense of obtaining a custom night guard can be prohibitive, forcing many to seek over-the-counter alternatives or forgo treatment altogether. This financial hurdle is particularly pronounced in low- and middle-income regions, where access to affordable dental care remains limited.
To address this challenge, manufacturers and healthcare providers are exploring ways to reduce costs without compromising quality. Innovations such as digital scanning and 3D printing have streamlined the production process, offering a more cost-effective alternative to traditional methods. Additionally, some companies are introducing subscription-based models or financing options to make custom-fit night guards more accessible. Despite these advancements, cost remains a key restraint, highlighting the need for continued innovation and policy support to ensure that effective bruxism treatment is affordable and widely available.
Opportunities
- Untapped Markets Of The Asia-Pacific Region
-
Rising Prevalence Of Obstructive Sleep Apne:The rising prevalence of obstructive sleep apnea (OSA) has created a growing demand for integrated treatment solutions that address both bruxism and sleep-disordered breathing. Many patients with OSA also experience bruxism as a comorbid condition, with the two disorders often exacerbating each other. This overlap has prompted healthcare providers to adopt a multidisciplinary approach, combining continuous positive airway pressure (CPAP) therapy, oral appliances, and lifestyle modifications to manage both conditions effectively. These integrated strategies not only improve sleep quality but also reduce the risk of associated health complications, such as cardiovascular disease and metabolic disorders.
Innovative treatment devices that target both bruxism and OSA have gained traction in the market, offering patients a convenient and comprehensive solution. For example, mandibular advancement devices (MADs) are increasingly used to alleviate airway obstruction while simultaneously preventing teeth grinding. These dual-purpose appliances have become particularly popular among patients seeking non-invasive alternatives to CPAP therapy. As awareness of the connection between bruxism and OSA grows, the demand for holistic treatment approaches is expected to drive market growth, encouraging further research and product development in this area.
Competitive Landscape Analysis
Key players in Global Sleeping Bruxism Treatment Market include:
- Ivoclar Vivadent AG
- Ipsen Biopharmaceuticals, Inc.
- Merz Pharma GmbH & Co. KGaA
- Carestream Dental 1
- Akervall Technologies Inc
- PLANMECA OY
- Randmark Dental Products, LLC
- S4S Dental Laboratory
- Patterson Dental Supply, Inc.
- Pfizer Inc.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Diagnosis
- Market Snapshot, By Treatment Type
- Market Snapshot, By Cause
- Market Snapshot, By End User
- Market Snapshot, By Region
- Sleeping Bruxism Treatment Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing Prevalence Of Sleep Bruxism
- Growing Child Population
- Restraints
- Limited Availability Of Treatment Options
- High Cost Of Custom Fit Night Guards
- Opportunities
- Untapped Markets Of The Asia-Pacific Region
- Rising Prevalence Of Obstructive Sleep Apnea
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Sleeping Bruxism Treatment Market, By Type, 2021 - 2031 (USD Million)
- Primary Bruxism
- Secondary Bruxism
- Sleeping Bruxism Treatment Market, By Diagnosis, 2021 - 2031 (USD Million)
- Clinical Examination
- X-Rays
- Electromyographic Methods
- Polysomnography
- Sleeping Bruxism Treatment Market, By Treatment Type, 2021 - 2031 (USD Million)
- Dental Approaches
- Medication
- Sleeping Bruxism Treatment Market, By Cause, 2021 - 2031 (USD Million)
- Obstructive Sleep Apnea
- Gastroesophageal Reflux Disease (GERD)
- Malocclusion
- Sleep Paralysis
- Sleeping Bruxism Treatment Market, By End User, 2021 - 2031 (USD Million)
- Hospitals
- Dental Clinics
- Sleeping Bruxism Treatment Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Sleeping Bruxism Treatment Market, By Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Ivoclar Vivadent AG
- Ipsen Biopharmaceuticals, Inc.
- Merz Pharma GmbH & Co. KGaA
- Carestream Dental 1
- Akervall Technologies Inc
- PLANMECA OY
- Randmark Dental Products, LLC
- S4S Dental Laboratory
- Patterson Dental Supply, Inc.
- Pfizer Inc.
- Company Profiles
- Analyst Views
- Future Outlook of the Market